Tag: FDA

iPLEDGE is the FDA's mandatory program to prevent birth defects from isotretinoin. Learn the updated 2026 requirements, what changed in 2023, and how to navigate the system without delays.

Recent-posts

Irbesartan/HCTZ and Potassium: What You Need to Know

Oct, 18 2025

Neuropathy in Diabetes: How to Manage Pain and Protect Nerves

Jan, 28 2026

Polysomnography: What to Expect During a Sleep Study and How Results Are Interpreted

Jan, 11 2026

Anticholinergics and Urinary Retention: How Prostate Problems Make This Medication Risky

Dec, 19 2025

Sore Throat in Pregnancy: Safe Relief, Red Flags, and UK Guidance

Aug, 29 2025